Patients with lung adenocarcinoma – the most common type of cancer among non-smokers -- carry a specific mutation in the ...

India's gene therapy for blood cancers shows 73% response rate, offering hope and cost-effective treatment for patients.

Patients with lung adenocarcinoma typically carry a mutation in the Epidermal Growth Factor Receptor (EGFR) gene, making them ...

Goa CM Pramod Sawant said blood samples of more than 1 lakh people would be collected as part of the study, and diagnosis ...

The study, published in The Lancet Haematology, has revealed that the injection had a 73% response rate among Indian patients ...

A new study published in The Lancet Haematology journal says that an indigenously developed gene therapy for certain blood ...

An indigenously developed gene therapy for specific blood cancers has shown a 73 per cent response rate among patients in ...

The study looked at patients with leukaemia, which occurs in bone marrow, and lymphoma, which affects the lymphatic system.

Of these, more than 4.5 lakh treatments worth over Rs 985 crore were undertaken for "targeted therapies" against cancer, with ...

The Car-T cell therapy was tested on patients with B-cell leukaemia and lymphoma - rare types of blood cancers - that affect the bone marrow and the lymphatic system.

In a statement, Everhope Oncology said it will focus on providing comprehensive cancer treatment, including chemotherapy, ...